Replies to post #250216 on Biotech Values

[DewDiligence]

LBPH seeking $172.5M* of cash:

https://www.businesswire.com/news/home/20240102974170/en

*Assuming exercise of underwriter’s option.

[DewDiligence]

LBPH sells—(upsized)—11.5M* shares @$21.00—a 16% discount to Monday’s close:

https://www.businesswire.com/news/home/20240103727932/en

Net proceeds will be about $227M.*

*Assuming exercise of underwriter’s option.

[Mufaso]

Lundbeck to Acquire Longboard Pharmaceuticals for $60 (a $2.6B deal) and the stock is up approx 45% pre market. Longboard Pharmaceuticals was a spinout of the former Arena Pharmaceuticals prior to Arena being purchased by PFE (Pfizer acquired Arena Pharmaceuticals for $6.7 billion in March 2022.) Longboard (a San Diego company) has a focus on GPCRs' for Neurological And Rare Diseases.

Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline

https://finance.yahoo.com/news/lundbeck-acquire-longboard-pharmaceuticals-strategic-103000932.html